Targeted Oncology5 小时
Odronextamab Shows Efficacy in DLBCL Post CAR T-Cell Therapy
Matthew Matasar, MD, discussed what the findings from the ELM-1 trial of odronextamab in diffuse large B-cell lymphoma mean ...